As CK-18 is considered an accessory diagnostic and prognostic biomarker in acute and chronic liver diseases, especially MAFLD, it is important to understand the relationship of CK-18 M30 with various metabolic and inflammatory factors that are altered in obesity [22]. This evidence concerns the gene KRT18 and obesity disorder.